BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 11480044)

  • 21. [Embolization and degradation of arteries in vivo by pingyangmycin albumin microspheres].
    Wang LL; Gao QH; Zheng GJ; Wang XY; Zhou L; Wang CM; Wen YM
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Mar; 40(2):279-83. PubMed ID: 19462907
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effect of pingyangmycin on the growth and cell cycle of human vascular endothelial cells].
    Kong WD; Li YH; Zeng QL; Chen Y; He XF
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Aug; 23(8):830-2, 836. PubMed ID: 12919911
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sclerosing therapy as first line treatment for low flow vascular lesions of the orbit.
    Schwarcz RM; Ben Simon GJ; Cook T; Goldberg RA
    Am J Ophthalmol; 2006 Feb; 141(2):333-9. PubMed ID: 16458690
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recombinant full-length tissue factor pathway inhibitor (TFPI) prevents thrombus formation and rethrombosis after lysis in a rabbit model of jugular vein thrombosis.
    Kaiser B; Fareed J
    Thromb Haemost; 1996 Oct; 76(4):615-20. PubMed ID: 8903005
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dose- and time-dependent liquid sclerosant effects on endothelial cell death.
    Kobayashi S; Crooks S; Eckmann DM
    Dermatol Surg; 2006 Dec; 32(12):1444-52. PubMed ID: 17199651
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The effect of pinyangmycin, dexamethasonum and sodium morrhuate injected concomitantly to treat cavernous hemangioma].
    Shou BQ; Shou WD; Meng ZY; Yang Z; Zhang SL
    Shanghai Kou Qiang Yi Xue; 2003 Feb; 12(1):9-11. PubMed ID: 14661451
    [TBL] [Abstract][Full Text] [Related]  

  • 27. X-ray contrast media induce aortic endothelial damage, which can be prevented with prior heparin treatment.
    Aliev G; Obrenovich ME; Seyidova D; Rzayev NM; Aliyev AS; Raina AK; Lamanna JC; Smith MA; Perry G
    J Submicrosc Cytol Pathol; 2003 Jul; 35(3):253-66. PubMed ID: 14690173
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute respiratory failure after sodium morrhuate esophageal sclerotherapy.
    Monroe P; Morrow CF; Millen JE; Fairman RP; Glauser FL
    Gastroenterology; 1983 Sep; 85(3):693-9. PubMed ID: 6603387
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The influence of 5-fluorouracil on the endothelium in small arteries. An electron microscopic study in rabbits.
    Cwikiel M; Zhang B; Eskilsson J; Wieslander JB; Albertsson M
    Scanning Microsc; 1995 Jun; 9(2):561-76. PubMed ID: 8714749
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Experimental study of magnetic pingyangmycine-bearing microspheres in the treatment of cavernous hemangioma].
    Zhang S; Wu HJ; Ling TY
    Hunan Yi Ke Da Xue Xue Bao; 2003 Feb; 28(1):23-5. PubMed ID: 12934388
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The hemodynamic effects of the sclerosant sodium morrhuate in dogs.
    Camara DS; Caruana JA; Chung RS; Amodeo DJ
    Surg Gynecol Obstet; 1985 Oct; 161(4):327-31. PubMed ID: 4049201
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effects of thrombus, thrombectomy and thrombolysis on endothelial function.
    Reil TD; Moore WS; Kashyap VS; Nene SS; Gelabert HA; Quinones-Baldrich WJ
    Eur J Vasc Endovasc Surg; 2000 Feb; 19(2):162-8. PubMed ID: 10727365
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vascular endothelial growth factor (VEGF)-eluting stents: in vivo effects on thrombosis, endothelialization and intimal hyperplasia.
    Swanson N; Hogrefe K; Javed Q; Malik N; Gershlick AH
    J Invasive Cardiol; 2003 Dec; 15(12):688-92. PubMed ID: 14660819
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Corticosteroids inhibit VEGF-induced vascular leakage in a rabbit model of blood-retinal and blood-aqueous barrier breakdown.
    Edelman JL; Lutz D; Castro MR
    Exp Eye Res; 2005 Feb; 80(2):249-58. PubMed ID: 15670803
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effect of 2 antimitotic antibiotics (mitomycin and bleomycin) on the electrokinetic charge of human blood cells].
    Stoltz JF; Larcan A; Genetet B; Streiff F
    C R Seances Soc Biol Fil; 1972; 166(1):177-9. PubMed ID: 4118284
    [No Abstract]   [Full Text] [Related]  

  • 36. [Classification and mechanism of action of sclerosing agents].
    Imhoff E; Stemmer R
    Phlebologie; 1969; 22(2):145-8. PubMed ID: 5382245
    [No Abstract]   [Full Text] [Related]  

  • 37. [Fibrinolytic activity of the vein wall].
    Lindemayer H; Santler R
    Phlebologie; 1977; 30(2):151-60. PubMed ID: 333476
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sympatholytic interventions and vascular remodelling.
    Lee RM; Gzik DJ
    Basic Res Cardiol; 1991; 86 Suppl 1():55-64. PubMed ID: 2036096
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fibroblast proliferation by bleomycin stimulated peripheral blood mononuclear cell factors.
    Yamamoto T; Katayama I; Nishioka K
    J Rheumatol; 1999 Mar; 26(3):609-15. PubMed ID: 10090171
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of interleukin-1 on venous endothelium--an ultrastructural study.
    Merton RE; Hockley D; Gray E; Poole S; Thomas DP
    Thromb Haemost; 1991 Dec; 66(6):725-9. PubMed ID: 1796418
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.